Donald Trump is starting to win over biopharma
It would appear that Donald Trump is starting to win over the minds — though perhaps not the hearts — of the biopharma industry.
After we ran two earlier polls reflecting a deep distaste for the Republican, Trump’s upset victory followed by a surge in industry stocks was followed by a respectable show of support in our latest poll of biotech and pharmaceutical industry readers.
With 165 votes in, close to half (46%) felt that biopharma would be better off under Trump a year from now. That compares to 28% who felt it will be worse and 26% who felt that it will be no different on the anniversary of his win.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.